Chevron delivers mixed earnings for fourth quarter

Chevron reported mixed Q4 results with adjusted earnings of $3.0 billion ($1.52/share) beating estimates of about $1.45, while GAAP net income was $2.77 billion and revenue missed at $46.87 billion versus ~$47.15 billion expected. Production rose 20.7% to 4.045 million boe/d driven by the Hess acquisition and Permian/Gulf growth; operating cash flow was $10.8 billion with adjusted free cash flow of $4.2 billion. Management cited lower crude prices, pension settlement and FX impacts on year-over-year results, announced a 4% quarterly dividend increase to $1.78, and highlighted project starts (Gulf of America, Tengizchevroil) and progress on lithium, hydrogen and power initiatives.

Analysis

Market structure: Chevron’s 20.7% q/q production jump to 4.045 mbd (driven by Hess, Permian and Gulf of America) shifts incremental supply toward integrated majors, benefiting CVX shareholders (higher FCF, 4.1% current yield) and midstream/service providers with Permian exposure while pressuring higher‑cost pure E&Ps. The modest miss on revenue but +$4.2bn adjusted FCF implies pricing power through scale and cost cuts ($1.5bn structural savings) even if Brent softens; a ~0.8% global supply increase (relative to ~100 mbd demand) is non‑trivial for short-term oil balances.

Risk assessment: Tail risks include sanction or asset‑loss exposure in Venezuela, a sustained Brent < $60 for two quarters that would materially compress FCF (stress test: cut free cash flow by >30%), and integration/execution slippage on Hess synergies over the next 12–18 months. Near term (days/weeks) the biggest risks are oil vol shocks and FX/pension hits to quarterly earnings; medium term (3–12 months) watch project start‑up reliability and capex discipline.

Trade implications: Tactical: establish a core long in CVX to capture yield + FCF upside, use covered calls to enhance income and buy limited‑cost downside protection (puts). Relative value: prefer CVX vs high‑beta E&Ps (e.g., OXY) or vs majors lacking recent accretive M&A — dollar‑neutral long CVX / short OXY or short XOP over 3–12 months. Cross‑asset: tighten credit spreads for CVX bonds and lower equity IV expected; hedge commodity exposure if owning upstream names.

Contrarian angles: Consensus underprices operational upside from Hess integration and $1.5bn cost cuts — if 50–70% of synergies materialize within 12 months, CVX EPS/FCF could re‑rate. Conversely, the market may be underestimating geopolitical tail risk (Venezuela) and pension cash outflows; these could force buyback pauses. Historically, majors post‑M&A often see 12–18 month performance divergence; watch realization milestones (Permian ramp, Tengiz output) as binary catalysts.

Key Decisions for Investors

• Establish a 2–3% long position in CVX (buy up to $175; add on pullback to ≤ $165). Target hold 6–18 months to capture dividend (annual $7.12 ≈ 4.1% yield) and FCF lift; trim into strength above $190 (take profits on 25% of position).
• Sell 1–2% covered calls against the CVX position: short 3‑month calls ~+5–7% OTM (e.g., Apr‑2026 $185) to enhance yield; roll if shares are called or if Brent rises >$10 from current levels.
• Buy downside protection: purchase 6‑month CVX $155 puts sized to cover ~30–40% of the long position (cost‑effective hedge if CVX drops >10% or Brent < $70 for 30 days).
• Pair trade (dollar‑neutral): Long CVX 2% vs Short OXY 1.5% (or short XOP ETF) to capture relative stability from integrated scale; horizon 3–12 months, unwind if CVX underperforms by >8% or OXY weakens by <‑12%.
• Monitor 3 milestones within 90–180 days before scaling: 1) Permian production ramp details (volumes/cost per boe), 2) Tengiz/Future Growth project stabilization, 3) any US‑Venezuela policy shifts — add exposure if two of three meet targets and Brent > $80 for 60 days.